Description
RADIOPHARMACEUTICALS - FUND OPTION LINE ITEM 0005
Base award description: RADIOPHARMACEUTICALS
Modification chain · 15 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-06-05+$134,412= $134,412
- Mod P000012017-09-01+$0= $134,412
- Mod P000022017-10-17+$336,495= $470,907
- Mod P000032018-01-17-$15,560= $455,347
- Mod P000042018-09-11+$0= $455,347
- Mod P000052018-10-01+$357,803= $813,150
- Mod P000062019-08-27+$0= $813,150
- Mod P000072019-10-01+$357,803= $1,170,952
- Mod P000082019-10-23+$50,000= $1,220,952
- Mod P000092020-06-02-$49,852= $1,171,100
- Mod P000102020-08-28+$0= $1,171,100
- Mod P000112020-10-01+$390,124= $1,561,225
- Mod P000122022-06-10-$162,592= $1,398,632
- Mod P000132023-02-15-$14,084= $1,384,548
- Mod P000142024-05-08-$154,335= $1,230,213
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-06-05 | +$134,412 | $134,412 | RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2017-09-01 | +$0 | $134,412 | RADIOPHARMACEUTICALS - EXERCISE OPTION FOR ITEM NUMBER 0002 |
| Mod P00002· FUNDING ONLY ACTION | 2017-10-17 | +$336,495 | $470,907 | RADIOPHARMACEUTICALS - FUND OPTION LINE ITEM 0002 |
| Mod P00003· FUNDING ONLY ACTION | 2018-01-17 | −$15,560 | $455,347 | RADIOPHARMACEUTICALS - DELETE EXCESS FUNDS ON PO# C70216 AND CLOSE OUT |
| Mod P00004· EXERCISE AN OPTION | 2018-09-11 | +$0 | $455,347 | RADIOPHARMACEUTICALS - EXERCISE LINE ITEM QUANTITY |
| Mod P00005· FUNDING ONLY ACTION | 2018-10-01 | +$357,803 | $813,150 | RADIOPHARMACEUTICALS - FUND OPTION YEAR 1 |
| Mod P00006· EXERCISE AN OPTION | 2019-08-27 | +$0 | $813,150 | RADIOPHARMACEUTICALS - EXERCISE OPTION YEAR 3 |
| Mod P00007· FUNDING ONLY ACTION | 2019-10-01 | +$357,803 | $1,170,952 | RADIOPHARMACEUTICALS - FUND LINE ITEM 4 |
| Mod P00008· FUNDING ONLY ACTION | 2019-10-23 | +$50,000 | $1,220,952 | RADIOPHARMACEUTICALS - INCREASE FUNDING |
| Mod P00009· FUNDING ONLY ACTION | 2020-06-02 | −$49,852 | $1,171,100 | RADIOPHARMACEUTICALS - DELETE FY 18 EXCESS FUNDING C80152 |
| Mod P00010· EXERCISE AN OPTION | 2020-08-28 | +$0 | $1,171,100 | RADIOPHARMACEUTICALS - EXERCISE OPTION LINE ITEM 0005 |
| Mod P00011· FUNDING ONLY ACTION | 2020-10-01 | +$390,124 | $1,561,225 | RADIOPHARMACEUTICALS - FUND OPTION LINE ITEM 0005 |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-06-10 | −$162,592 | $1,398,632 | RADIOPHARMACEUTICALS - FUND OPTION LINE ITEM 0005 |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2023-02-15 | −$14,084 | $1,384,548 | RADIOPHARMACEUTICALS - FUND OPTION LINE ITEM 0005 |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-05-08 | −$154,335 | $1,230,213 | RADIOPHARMACEUTICALS - FUND OPTION LINE ITEM 0005 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NULVGFUNYLS9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0409 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $266,038 | FY2026 |
| 36C25625N0618 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $216,573 | FY2025 |
| 36C25624N0616 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $264,691 | FY2024 |
| 36C25623P0794 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $48,686 | FY2023 |
| 36C25623N0686 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $155,196 | FY2023 |
| 36C25623A0025 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
Other recipients under 3650 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25624P0029 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $126,932 | FY2024 |
| VA25617F1883 | CAPSA SOLUTIONS LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $25,165 | FY2017 |
| VA25617P1140 | UNITED LAB CO LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $7,377 | FY2017 |
| VA25617P0658 | AKORN, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $22,570 | FY2017 |
| VA25616P1024 | MCKESSON PLASMA AND BIOLOGICS LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $8,282 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25617C0116_3600_-NONE-_-NONE- · retrieved 2026-09-26.